Article
Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells.
Molecular carcinogenesis - 1 Oct 2021
Hu Xiao, Liu Zhanzhao, Duan Xianxian, Han Xiao, Yuan Mengci, Liu Lingyan, Xia Xiaojun, Li Ning, Qin Junfang, Wang Yue
Abstract excerpt
Monocarboxylate transporter 4 (MCT4) is highly expressed in various types of solid neoplasms including breast cancer (BC); however, the pro-tumor functions underlying its increased expression have not been explained. Here, we examined the roles of posttranslational modifications to MCT4 in BC, particularly SUMOylation. Our findings revealed that SUMOylation of MCT4 inhibited its degradation and stabilized MCT4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
